0000711665-12-000009.txt : 20120402 0000711665-12-000009.hdr.sgml : 20120402 20120402155525 ACCESSION NUMBER: 0000711665-12-000009 CONFORMED SUBMISSION TYPE: 10-K/A PUBLIC DOCUMENT COUNT: 6 CONFORMED PERIOD OF REPORT: 20111231 FILED AS OF DATE: 20120402 DATE AS OF CHANGE: 20120402 FILER: COMPANY DATA: COMPANY CONFORMED NAME: PHOTOMEDEX INC CENTRAL INDEX KEY: 0000711665 STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845] IRS NUMBER: 592858100 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-K/A SEC ACT: 1934 Act SEC FILE NUMBER: 000-11635 FILM NUMBER: 12733235 BUSINESS ADDRESS: STREET 1: 147 KEYSTONE DRIVE CITY: MONTGOMERYVILLE STATE: PA ZIP: 18936 BUSINESS PHONE: 2156193600 MAIL ADDRESS: STREET 1: 147 KEYSTONE DRIVE CITY: MONTGOMERYVILLE STATE: PA ZIP: 18936 FORMER COMPANY: FORMER CONFORMED NAME: LASER PHOTONICS INC DATE OF NAME CHANGE: 19920703 10-K/A 1 form_10-ka.htm AMENDED FILING TO 10K DEC_2011 form_10-ka.htm

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-K/A
(Mark One)
[X]           ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934

For the fiscal year ended December 31, 2011
OR
 
[  ]
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from ______________ to _____________
Commission file number: 0-11635
 
 
PHOTOMEDEX, INC.
(Exact name of registrant as specified in its charter)
 
Nevada
(State or other jurisdiction
of incorporation or organization)
  
59-2058100
(I.R.S.  Employer
Identification No.)
  

147 Keystone Drive, Montgomeryville, Pennsylvania 18936
(Address of principal executive offices, including zip code)
(215) 619-3600
(Issuer’s telephone number, including area code)
Securities registered under Section 12(b) of the Exchange Act:

 
 
Title of each class
None
  
Name of each exchange
on which registered
None
  

Securities registered under Section 12(g) of the Exchange Act:
Common Stock, $0.01 par value per share
(Title of Class)
Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. 
Yes [ ] No [X]

Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Exchange Act.
Yes [ ] No [X]

 

 
 
 


Indicate by check mark whether the registrant:  (i) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (ii) has been subject to such filing requirements for the past 90 days.

Yes [X] No [__]

Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K is not contained herein and will not be contained, to the best of registrant’s knowledge, in definitive proxy or information statements incorporated by reference in Part III of this Form 10-K or any amendment to this Form 10-K.  [X]

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).

Yes [X] No [__]
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See definitions of "large accelerated filer," “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.

 
Large accelerated filer [__]
Accelerated filer [__]
  
       
 
Non-accelerated filer [__]
Smaller reporting company [X]
  

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act).

Yes [ ] No [X]

The number of shares outstanding of our common stock as of June 30, 2011, was 3,117,775 shares. The aggregate market value of the common stock held by non-affiliates (2,404,923 shares), based on the closing market price ($5.21) of the common stock as of June 30, 2011 was $12,529,649.

As of March 29, 2012, the number of shares outstanding of our common stock was 18,855,915. The closing market price of our common stock as of March 29, 2012 was $12.80.






















 

 
 
 


Explanatory Note:

This Amendment No. 1 to the Annual Report on Form 10-K for the fiscal year ended December 31, 2011 (the “Annual Report”) of PhotoMedex, Inc. (the “Registrant”) is being filed solely to attach the consent dated March 30, 2012 of Fahn Kanne & Co. Grant Thornton Israel to Exhibit 23.1 and remove the opinion of the firm from Exhibit 23.1.  The opinion, dated March 30, 2012, of the firm is otherwise found at F-2, Report of Independent Public Accounting Firm.



 
- 1 -
 

PART IV
 
Item 15. Exhibits
 
(b)      Exhibits
 
In selected examples there is, following the footnote reference, the number of the exhibit in the original filing (e.g. “Exhibit 4.12”) in which it was submitted to the SEC.
 
2.1
  
Amended and Restated Agreement and Plan of Merger, dated as of October 31, 2011, by and among Radiancy, Inc., PhotoMedex, Inc. and PHMD Merger Sub, Inc., including the Form of Warrant. (23)
3.1
  
Amended and Restated Articles of Incorporation of PhotoMedex, Inc. a Nevada corporation, filed on December 12, 2011 with the Secretary of State for the State of Nevada. (23)
3.2
  
Bylaws of PhotoMedex, Inc. (a Nevada corporation), adopted December 28, 2010 (18)
4.1
  
Form of Warrant to Purchase Shares of Common Stock of PhotoMedex (19)
4.2
  
Term Loan and Security Agreement, dated as of March 19, 2010 between PhotoMedex, Inc. and Clutterbuck Funds LLC (26) (Exhibit 4.12 therein)
4.3
  
Term Note, dated March 19, 2010, between PhotoMedex, Inc. and Clutterbuck Funds, LLC (26) (Exhibit 4.13 therein)
4.4
  
Amendment No. 1 to Term Loan and Security Agreement, dated April 30, 2010 (27) (Exhibit 4.20 therein)
4.5
  
Amendment No. 2 to Term Loan and Security Agreement, dated March 28, 2011 (27) (Exhibit 4.21 therein)
10.1
  
Lease Agreement dated May 29, 1996, between Surgical Laser Technologies, Inc. and Nappen & Associates (Montgomeryville, Pennsylvania) (2)
10.2
  
Lease Renewal Agreement, dated January 18, 2001, between Surgical Laser Technologies, Inc. and Nappen & Associates (2)
10.3
  
Lease Agreement, dated July 10, 2006, PhotoMedex, Inc. and Nappen & Associates (3)
10.4
  
Standard Industrial/Commercial Multi-Tenant Lease - Net, dated July 30, 2008 (additional facility at Carlsbad, California) (15)
10.5
  
Standard Industrial/Commercial Multi-Tenant Lease  Net, dated March 17, 2005 (Carlsbad, California) (5)
10.6
  
License and Development Agreement, dated May 22, 2002, between Surgical Laser Technologies, Inc. and Reliant Technologies, Inc. (2)
10.7
  
Settlement Agreement and Release, dated November 11, 2008, by and among Allergan, Inc., Murray A. Johnstone, MD, PhotoMedex, Inc. and ProCyte Corporation. (15)
10.8
  
Master Asset Purchase Agreement, dated September 7, 2004, between PhotoMedex, Inc. and Stern Laser, srl (6)
10.9
  
License Agreement, dated March 31, 2006, and effective April 1, 2006, between the Mount Sinai School of Medicine and PhotoMedex, Inc. (7)
10.10
  
2005 Equity Compensation Plan, approved December 28, 2005 (8)
10.11
  
Amended and Restated 2000 Non-Employee Director Stock Option Plan (1)
10.12
  
Amended and Restated 2000 Stock Option Plan (1)
10.13
  
1996 Stock Option Plan, assumed from ProCyte (9)
10.14
  
Amended and Restated Employment Agreement with Dennis M. McGrath, dated September 1, 2007 (12)
10.15
  
Amended and Restated Employment Agreement of Michael R. Stewart, dated September 1, 2007 (12)
10.16
  
Restricted Stock Purchase Agreement of Dennis M. McGrath, dated January 15, 2006 (5)
10.17
  
Consulting Agreement dated January 21, 1998 between the Company and R. Rox Anderson, M.D. (4)
10.18
  
Restricted Stock Purchase Agreement of Dennis M. McGrath, dated May 1, 2007 (10)
10.19
  
Restricted Stock Purchase Agreement of Michael R. Stewart, dated May 1, 2007 (10)
10.20
  
Restricted Stock Purchase Agreement of Michael R. Stewart, dated August 13, 2007 (11)
10.21
  
Amended and Restated 2000 Non-Employee Director Stock Option Plan, dated as of June 26, 2007 (24)
10.22
  
Amended and Restated 2005 Equity Compensation Plan, dated as of June 26, 2007, as amended on October 28, 2008 (14)
10.23
  
Form of Indemnification Agreement for directors and executive officers of PhotoMedex, Inc. (13)
10.24
  
Restricted Stock Purchase Agreement of Dennis M. McGrath, dated June 15, 2009 (16)
10.25
  
Restricted Stock Purchase Agreement of Michael R. Stewart, dated June 15, 2009 (16)
10.26
  
Co-Promotion Agreement, dated as of January 7, 2010, between PhotoMedex, Inc and Galderma Laboratories, L.P. (17)

 
- 2 -
 


10.27
  
Amended and Restated 2000 Non-Employee Director Stock Option Plan, dated as of August 3, 2010 (18)
10.28
  
Amended and Restated 2005 Equity Compensation Plan, dated as of August 3, 2010. (18)
10.29
  
Restricted Stock Agreement of Dennis M. McGrath, dated March 30, 2011 (18)
10.30
  
Restricted Stock Agreement of Michael R. Stewart, dated March 30, 2011 (18)
10.31
  
Restricted Stock Agreement of Christina L. Allgeier, dated March 30, 2011 (18)
10.32
  
Amended and Restated Employment agreement, entered into by and between PhotoMedex, Inc. and Dennis McGrath on July 4, 2011. (19)
10.33
  
Amended and Restated Restricted Stock Agreement, entered into as of August 11, 2011, by and between PhotoMedex, Inc. and Dennis McGrath. (20)
10.34
  
Restricted Stock Agreement, entered into as of July 4, 2011, by and between PhotoMedex, Inc. and Dennis McGrath. (19)
10.35
  
Non-Qualified Stock Option Agreement, entered into as of July 4, 2011, by and between PhotoMedex, Inc. and Dennis McGrath. (19)
10.36
  
Amended and Restated Employment agreement, entered into by and between PhotoMedex, Inc. and Michael Stewart on July 4, 2011. (19)
10.37
  
Amended and Restated Restricted Stock Agreement, entered into as of August 11, 2011, by and between PhotoMedex, Inc. and Michael Stewart. (20)
10.38
  
Amended and Restated Restricted Stock Agreement, entered into as of July 4, 2011, by and between PhotoMedex, Inc. and Michael Stewart. (19)
10.39
  
Non-Qualified Stock Option Agreement, entered into as of July 4, 2011, by and between PhotoMedex, Inc. and Michael Stewart. (19)
10.40
  
Amended and Restated Employment Agreement entered into by and between PhotoMedex, Inc. and Dolev Rafaeli on August 9, 2011. (21)
10.41
  
Distribution Agreement by and between Radiancy, Inc. and Ya-Man Ltd., dated October 17, 2008. (21)
10.42
  
Distribution Agreement Extension by and between Radiancy, Inc. and Ya-Man Ltd., dated August 12, 2010. (21)
10.43
  
First Amendment to the Nonqualified Stock Option Agreement, dated as of October 31, 2011, by and between PhotoMedex, Inc. and Dennis McGrath (22)
10.44
  
First Amendment to the Nonqualified Stock Option Agreement, dated as of October 31, 2011, by and between PhotoMedex, Inc. and Michael R. Stewart (22)
10.45
  
Lease Renewal Agreement, dated June 6, 2011, PhotoMedex, Inc. and Nappen & Associates (25)
10.46
  
Lease Agreement dated September 1, 2010, by and between 30 Ramland Road, LLC and Radiancy, Inc. (Orangeburg). (25)
10.47
  
Unprotected Tenancy Agreement dated September 9, 2008 by and between S.A.I. Yarak Buildings and Investments Ltd. and Radiancy (Israel) Ltd. (Hod Hasharon) (25)
10.48
  
Amendment to Unprotected Tenancy Lease, dated as of January 20, 2008, by and between S.A.I. Yarak Buildings and Investments Ltd. and Radiancy (Israel) Ltd. (25)
10.49
  
Exclusive License Agreement for Methods of Treating Diseased Tissue, dated April 1, 2012, by and between the Regents of the University of California and PhotoMedex, Inc. (25)
10.50
  
Non-Qualified Stock Option Agreement dated March 18, 2012 between PhotoMedex, Inc. and Dolev Rafaeli (25)
10.51
  
Non-Qualified Stock Option Agreement dated March 18, 2012 between PhotoMedex, Inc. and Dennis McGrath (25)
21.1
  
List of subsidiaries of the Company
23.1
  
Consent of Fahn Kanne & Co. Grant Thornton Israel
31.1
  
Rule 13a-14(a) Certificate of Chief Executive Officer
31.2
  
Rule 13a-14(a) Certificate of Chief Financial Officer
32.1
  
Certificate of Chief Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
32.2
  
Certificate of Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
101.INS*
  
XBRL Instance Document
101.SCH*
  
XBRL Taxonomy Schema
101.CAL*
  
XBRL Taxonomy Calculation Linkbase
101.DEF*
  
XBRL Taxonomy Definition Linkbase
101.LAB*
  
XBRL Taxonomy Label Linkbase
101.PRE*
  
XBRL Taxonomy Presentation Linkbase

 
- 3 -
 


*  
Pursuant to Rule 406T of Regulation S-T, the Interactive Data Files on Exhibit 101 hereto are deemed not filed or part of a registration statement or prospectus for purposes of Sections 11 or 12 of the Securities Act of 1933, as amended (the “Securities Act”), are deemed not filed for purposes of Section 18 of the Exchange Act, and otherwise not subject to liability under those sections. This exhibit shall not be deemed to be incorporated by reference into any filing under the Securities Act or the Exchange Act, except to the extent that the Registrant specifically incorporates this exhibit by reference.
.

(1)  
Filed as part of our Registration Statement on Form S-4, on October 18, 2002, and as amended.
 
(2)  
Filed as part of our Annual Report on Form 10-K for the year ended December 31, 2002.
 
(3)  
Filed as part of our Annual Report on Form 10-K for the year ended December 31, 2006.
 
(4)  
Filed as part of our Registration Statement on Form S-1/A, on August 5, 1999.
 
(5)  
Filed as part of our Annual Report on Form 10-K for the year ended December 31, 2005.
 
(6)  
Filed as part of our Current Report on Form 8-K, on September 13, 2004.
 
(7)  
Filed as part of our Current Report on Form 8-K, on April 10, 2006.
 
(8)  
Filed as part of our Definitive Proxy Statement on Schedule 14A on November 15, 2005.
 
(9)  
Filed as part of our Registration Statement on Form S-8 on April 13, 2005.
 
(10)  
Filed as part of our Quarterly Report on Form 10-Q for the quarter ended June 30, 2007.
 
(11)  
Filed as part of our Quarterly Report on Form 10-Q for the quarter ended September 30, 2007.
 
(12)  
Filed as part of our Annual Report on Form 10-K for the year ended December 31, 2007.
 
(13)  
Filed as part of our Current Report on Form 8-K on March 5, 2009.
 
(14)  
Filed as part of our Definitive Proxy Statement on Schedule 14A on December 18, 2008.
 
(15)  
Filed as part of our Annual Report on Form 10-K for the year ended December 31, 2008.
 
(16)  
Filed as part of our Quarterly Report on Form 10-Q for the quarter ended June 30, 2009.
 
(17)  
Filed as part of our Current Report on Form 8-K on January 11, 2010.
 
(18)  
Filed as part of our Annual Report on Form 10-K for the year ended December 31, 2010.
 
(19)  
 Filed as part of our Current Report on Form 8-K on July 8, 2011.
 
(20)  
 Filed as part of our Registration Statement on Form S-4 on August 12, 2011.
 
(21)  
Filed as part of our Registration Statement on Form S-4/A on October 5, 2011.
 
(22)  
Filed as part of our Registration Statement on Form S-4/A on November 2, 2011.
 
(23)  
Filed as part of our Current Report on Form 8-K on December 16, 2011.
 
(24)  
Filed as part of our Current Report on Form 8-K on July 2, 2007.
 
(25)  
Filed with this Form 10-K.
 
(26)  
Filed as part of our Current Report on form 8-K on March 23, 2010
 
(27)  
Filed as part of our Annual Report on Form 10-K for the year ended December 31, 2010.
 

 


 
- 4 -
 

SIGNATURES
 
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this Report to be signed on its behalf by the undersigned, thereunto duly authorized.
 
     
PHOTOMEDEX, INC.
  
         
 
Date:  April 2, 2012
  
By:/s/ Dr. Dolev Rafaeli
  
     
     Dr. Dolev Rafaeli
  
     
Chief Executive Officer and Director
  

 


- 5 -
 
 
 

 
 EX-23.1 2 ex_23-1.htm FAHN KANNE & CO. GRANT THRONTON ISRAEL CONSENT ex_23-1.htm
 

Exhibit 23.1

 
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
 
Fahn Kanne & Co.
Head Office
Levinstein Tower
23 Menachem Begin Road
Tel-Aviv 66184, ISRAEL
P.O.B. 36172, 61361
 
T +972 3 7106666
F +972 3 7106660
www.gtfk.co.il
 
 
 


 

We have issued our report dated March 30, 2012, with respect to the consolidated financial statements of PhotoMedex Inc. included in the annual report of PhotoMedex Inc. on Form 10-K for the year ended December 31, 2011. We hereby consent to the incorporation by reference of said report in the Registration Statement and Prospectus of PhotoMedex Inc. on Form S-3 (File No. 333-178751, effective January 13, 2012).
 

 

 
/s/FAHN KANNE & CO. GRANT THORNTON ISRAEL
 

Tel Aviv, Israel
March 30, 2012


 
 
23.1
 
 
 
 EX-31.1 3 ex_31-1.htm CERTIFICATION CEO ex_31-1.htm


Exhibit 31.1

CERTIFICATION OF CHIEF EXECUTIVE OFFICER
Rule 13a-14a/15d-14a Certification
 

 
I, Dolev Rafaeli, certify that:
 
 
(1)
I have reviewed this annual report on Form 10-K of PhotoMedex, Inc.;
 
 
(2)
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
 
 

 
 

     
PHOTOMEDEX, INC.
  
 
Dated: April 2, 2012
      
     
By: /s/ Dolev Rafaeli
  
     
       Dolev Rafaeli
  
     
       Chief Executive Officer
  
 
 
 

 

E-31.1



 EX-31.2 4 ex_31-2.htm CERTIFICATION CFO ex_31-2.htm



Exhibit 31.2

CERTIFICATION OF CHIEF FINANCIAL OFFICER
Rule 13a-14a/15d-14a Certification
 
I, Dennis M. McGrath, certify that:
 
 
(1)
I have reviewed this annual report on Form 10-K of PhotoMedex, Inc.;
 
 
(2)
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
 
 





     
PHOTOMEDEX, INC.
  
 
Dated: April 2, 2012
      
     
By: /s/ Dennis M. McGrath
  
     
Dennis M. McGrath
  
     
Chief Financial Officer
  



 
 

 

E-31.2

 
 
 GRAPHIC 5 qlogo.jpg PHMD LOGO begin 644 qlogo.jpg M_]C_X``02D9)1@`!`0$`8`!@``#_X0!F17AI9@``24DJ``@````$`!H!!0`! M````/@```!L!!0`!````1@```"@!`P`!`````@`!`3$!`@`0````3@`````` M``!@`````0```&`````!````4&%I;G0N3D54('8U+C`P`/_;`$,``@$!`0$! M`@$!`0("`@("!`,"`@("!00$`P0&!08&!@4&!@8'"0@&!PD'!@8("P@)"@H* M"@H&"`L,"PH,"0H*"O_;`$,!`@("`@("!0,#!0H'!@<*"@H*"@H*"@H*"@H* M"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"O_``!$(`$4! M5P,!(@`"$0$#$0'_Q``?```!!0$!`0$!`0```````````0(#!`4&!P@)"@O_ MQ`"U$``"`0,#`@0#!04$!````7T!`@,`!!$%$B$Q008346$'(G$4,H&1H0@C M0K'!%5+1\"0S8G*""0H6%Q@9&B4F)R@I*C0U-CH.$A8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJ MLK.TM;:WN+FZPL/$Q<;'R,G*TM/4U=;7V-G:X>+CY.7FY^CIZO'R\_3U]O?X M^?K_Q``?`0`#`0$!`0$!`0$!`````````0(#!`4&!P@)"@O_Q`"U$0`"`0($ M!`,$!P4$!``!`G<``0(#$00%(3$&$D%1!V%Q$R(R@0@40I&AL<$)(S-2\!5B M7J"@X2%AH>(B8J2DY25EI>8F9JBHZ2EIJ>HJ:JRL[2UMK>X MN;K"P\3%QL?(RKR\_3U]O?X^?K_V@`,`P$` M`A$#$0`_`/L+_@I(W_!77]@?X$:M^T_\.OVX-.\:>'M"N+<:SI>M^#;:"Z@A MFF2%94,8VR`/(@*X4@$GG!KQG_@EW^V)_P`%@O\`@JEXF\46>A_M7>'O!FB^ M$(+5M6U-/!\,\KR7!E\J../(&2(9"6)P-HX.:^XO^"\C?\:H/BX"/^8;8?\` MIRM:^*O^#1[_`)`OQX_Z^O#?_H.IU]-0G&625*\H1YT[)V7EY6ZGQ&*IU(<2 M4L+&I)0E%MKF>Z3ZWOT1]#?M'?"3_@M_^SC\/[WXN_!#]L/0/BHVBV[W6H>$ M=8\%0VMQ,-0U[7M>^(BO?ZKJETTTTQ6SBZLQS@9.!T`X'%>\_\%Z,M_P`$H?BH M2.38V!(_[?[>OGO_`(-4]CR)+2*^C:53[H# MD?E6KD8SFO`<7'<^MC*,M@``X%%&1ZUFZYXP\*>&%1O$?B?3]/\`,^Y]MO8X MMWTWD9H2;V"4HQ5V:5%5[#4M.U:V6_TJ_AN87&4EMY0Z-]"#@U-)(D2&21@J MJ,EB<`"E9W&I1:O<-Q`!HZ<9^G%?DU_P6C_X+E^'?`9C_9._8W^(22Z_O96=[+J_4\JEG.`K8F=&,U[ MMKNZM=]$?25%4=`UW1_%.AV?B;P]J4-[8:C:QW5C=V[AHYX9%#)(I'564@@^ MAIVKZ]H?A^U-]KNLVME"IP9KRX6)/S8@5QV=['JUVSOH0<>;9722KGZJ2*NGD8S2::",HR5T>`?M:_`S]M7XC:[%XI_95_:^M_ M`AMM-$0T'5/"L-]9W,X9F\UW)$B[@57C(&W.*_'6X_X+I_\`!3;X!_MBP?#' M]I7XDZ1<:?X1\:KIWC+2M-TB!(;F"*?9-MD"[MI7+!A@XQP.E?T#,Q"$D\X/ M-?S5_P#!0+]F&Y^('P$\2_\`!1WP];/,NI_'_P`3:+KDB\@6QNG-G*?;Y6C) MZ99!WKZ3(GAZ_-2KQ36B3LKW=^I\=Q.L5A5"MAIR4M6U=V:5NE_,_I)\/:_I M'BK0+'Q/H-XMQ9:A:1W-I.AXDB=0RL/J"*N@@]%KX5_X-[?VM/\`AIS_`()\ MZ1X:UW4O.\0?#J\;P]J@=\N\"*'M93WPT3!,]VB>ONH#`R3T[UX6*H2PV(G2 MENG8^GP.*CC<'"M':23_`,_N9\6_\%R/^"@/BG]@G]D:/7?A3KL=EXX\5:NF MG^&I7A60PJ@\RXGV,""%0`9(QF1?6OA__@EM^W)_P6(_X*:?$#6/A[X<_:=\ M/>&])\.V$=SK?B"Z\)0SS@.VU$B0;0SG!Y.`,9YZ5WO_``4?TL?MX?$_]I+X MIW"_:_!G[.WPOG\-^&LG=%/X@NRLMY,O;='&@0D?],C7F'_!IKJ[)\9_BUHF M>'\-6$P'N+AA_6OI*%"A0R6I/D3J1LVVD[7M;\&CX[%8O$XKB.G3YW&G*Z23 M:O;1OYM'[)?`KP1\1OA[\-[+PO\`%7XLW/C76X2[7?B"ZTZ*U:?]5]0U/3M)M'O\`4KZ&WAC&9)KB4(BCW)X%?+-N^Q2?V1_:^_[+]HQ\GF[/FV9ZXYK7#` M#):LF7QOX+BU8:#)XPTQ;XG`LFOXQ+GTV;L_I3BG>Z0IRC:S=C^?'_@IY^UG M_P`%./$O[8$'[$_[7'Q*L+"Q'B#2TF\/^")&BTN_@N)(GBX\]*_H!0`JI!Z"O=SCE^ MJ89QBE>+>BLKNQ\MPZZCQV+4Y.5I))MW=E>PZBJ^H:C8:5:/?:E>PV\,:Y>6 M>4(JCW)X%5]$\4>&O$L+7'ASQ#8WZ(<.]E=I*%/H2I.*\+EE:Y]5SQO8T**P MG^)/P\CNY+"7QSI"3PN4EA?4H@R,.H(+<&B7XF_#>"5;>7Q]HH=V"HG]IQ9) M/08W468[HW:*R=6\;>#O#U\FF:_XJTZRN)$WI#=WJ1LRYQD!B.,@U%'\0_`$ MUY#IMOXWTF2XN'"001ZC&SR,>@`#9)I6871MT444#"BBB@`HHHH`^0?^"\F? M^'3_`,7,G_F'6'_IRM:_.S_@V!_:E_9S_9[_`.%Q>'OCM\;O#'@ZYUZ30YM' M_P"$FUF&Q2[6`7PE"/,RJ64S1_+G/S9QP:_1/_@O)G_AT_\`%S(_YAUA_P"G M*UKX!_X-:/@C\'/C)H7QNC^+?PJ\.^)Q8W'AX67]O:+!=FWWKJ._RS*K%-VU M,=!BO/IYA3PF&E3PT6G+>3>MNR2/7JY16QV+A6QK_E%+\52.GV*PX_[B%O7YM?\$.OV5/VL?VQ?V7?%GPE\&?M(7/P MS^%@\6-)XDN_#*D:SK%TUO&/LPDR/*MP@!."-Q;!R!BOTF_X+U@C_@E+\51_ MTYV'/_;_`&]?//\`P:H_\F9>.>/^:@-_Z20UWX6M*AD$YQM=2ZJ_;N>7CZ%/ M$<4TJSM??30^<_^"F__!"G7?V%_@=>?M+-0;PO-%/K=MJ% MR8KJ"-G"_:8IHF!RKLN0>><@U]S?\$`_V[OB9^VW^R!=CXSZO)JGB?P1K`TF M^UF8?O;^$Q"2&20_Q2;3M9NK$9/))KU7_@L:B-_P3'^,@90?^*2?K_UVCKXN M_P"#37_DWWXKY_Z'*T_])!2G5GCLCG4K:RA))/K9V_S"GAZ>6<2PHX?2$XMN M-W:ZOKKZ'IO_``7@_P""O7B/]A7P_IW[/G[/E]"GQ'\36!NKC4F19#H=B6*) M(%.09I&5]@(.`I8CE:;%,07CW1RLVZ*0*ZY/SHP&&^:OT?\`V%_VM_AI M_P`%'?V0]+^,FDZ7&+;7K.;3?%&A2ON-G=`&.XMGQSM(;Y")GZ"E4A'%Y+]8E\<)6OU:TW^\=*I+`<1?4X?PY MQO;HGY=D['QC_P`%Q/V8/@)^SG_P4:T'X4?!/X9Z?X=\/7NDZ7+=Z38&3RI' MEF*R,=S$Y8=<&OUTTK_@A+_P2CUS0;&]OOV1--6::SB>1X/$6J1Y8J"3A;H# MK[5^87_!Q3*[?\%:/#L)/":+HFW\9S7[Z^$N?"^F`_\`/A#W_P!@5MF>)Q%/ M+\,XS:;CK9O7;$JYMC(SIII25DTFEZ=CY._P""H7[>?@/_`().?L>Z M9;_#?P_:-KDEG%H/PY\.RR,T4*01*@D?)+-%#&%ZG+':,\DU\M_\$L/^"?&N M_P#!1?X?']O+_@IQXU\1?$&X\3W4C>$/"VH:U<06%K:*Q7SO*A=`%9@=D:X4 M*N2&+<>%_P#!U[K6O3?M+_#70;AW&G0>#IYK5TW2 M-)_8+^$MCH>T6J>!=/\`+V#CF%2?U)K&I'ZCE%.I#XYMW?6W9/H;TI?VEG]2 MA57[NDE:/1MVU:ZGPU_P5'_X)C0_L5?!^_\`VYO^"9GBCQ'\-]?\#HM_X@T3 M0]>N9+2]L58>;)Y4KN#L'S,AS&R!LKQS]"_\$8/^"GT/_!1[X#7DWC2&UL_B M!X1:&W\56EJ-LOBO1M/:0V-[\,KIK^,'YJEUMV;ZCQ$GE>?T84=(54TX]+KJET^1^]OCOQ': M>#?!&L^+;Y]L.EZ5<7DS$]%BB9R?R6OSF_X)O?LM:=^U=_P08N_@WXHM5DG\ M>V^L7UO(ZY*7IN6D@E&>ZS1H0?:OL3_@H_XU/P\_8)^,'BP2['@^'>JQQ-G& M));5XD_\><5QG_!&?PU_PB?_``3#^#ND.@!;PJ+@C'7S9I)<_DXK@HRE1P3J M1WYE;Y)L]7%4X8G,HT9*ZY)7^;2_0_(;_@W=_:,UC]E+_@H5J7[-OQ`G>PL_ M&Z2Z+?VD[%5BU2V=C"2#_%D2)G_;K]O_`-MW]HO2?V3?V4_''Q^U212^@:'* M^G0GK<7LF(K:%?4O,\:_C[5^&'_!>WX!>)/V(_\`@II:_M"_#*-K&S\72V_B MK0KJ%,+!J4,H%Q'QW$J))C^[.!7W]\7/C_X?_P""KOQ7_9D_9W\"RB?PMJ^G M6WQ,^)]NC;E@M[5<16,N.YNPT9'X_P`->WF-"&+JTL9'X9*\ODKO_(^;R?%5 M3[L<*_[3N54>YK\D/\`@GWH_P`3O^"ZO[1O MB[]H3]N'XD:FOPM\'W<<.C?#VPUN2RT]YY,LD&V-U+!$&YY,[V+*-P&`/I?_ M`(.?M8UW3/\`@FQ;V6DR2"WO_B+I<&IA,X,`ANI`#[>;'%^.*\&_X-[?^"?? M['/[5'[$NL^/?CC\)K7Q%KEM\0+VRDN)KZ>,QPK:VCHFV-U&/G8YQGYJQP-* MEA\IGB6[2;LFE=I>6O4Z,RKU\7G]/!JSC%:5Q(R[PY4`J41] MR\9'VC_P2H_;LMO^"A7['^D?'*]L8;/7;6[ETGQ59P']W%J$*HSE?1722.0# ML),=JPI_^"(7_!+RY;S+G]E#1I&_O27=R3^LE=SI_P"S1\%_V(_V4/B#X9_9 M0^'-MX6MFT/5-76ST]W/F7_V(J)JZK169^:W[8?_``4?_:2_X*8?M_6/_!-?]B+X MFWOA'P4VOS:9K_BO1)VCN-0BM]QO+CSD(9;=5CD"*I'FG;DD,!7VUX&_X(4? M\$YO"G@M/#>M_"/4/$&IF$"Z\4:MXGOSJ$TN.90\0%4#US7Y7_`/!L M79Z?J?\`P4JU2_U9E:Z@\`:I+;;QSYC7%LK$>^UF_,U_0KR>O.:Z@^5))NVC;[MG%P_".:T9XO$I2E*32OJDET2>Q_-E_P4'^`6N_LS_P#!8?PM M\(M3^*FN^+['3_$/AI_#^I>);UKF]@T][B)HK625N9/*)=%)_A"].@_H/_:< M_:#\#?LJ_`/Q-^T!\1;ORM)\,:4]W.H(#3..(XE]6=RJ`>K"OP]_X+<_\IV_ M"?\`U]>$?_1Z5]W?\'.6LZ]IG_!,[[#I+R"WU#Q_I5OJFSH8`EQ*`WMYL<7X M@5TXR'UQX*,W\2U_"YPY;5^H1S"I37PMV^5['R_^P)8_%'_@NY^TKXN^/'[; M'Q)U.#X4>#;F./2?A[I^MR65A)-+N:.#$;*6VHNZ23.]BRC<`0!ZG_P5?_8W M^`7[`/P#/[;7_!/OXCR_"SQOX/U2R!TW1/%DKV^N037"0O"UO-,XD8"3>5`* MLBON4]1PO_!O%_P3_P#V//VJ_P!B[Q'XZ^.WPHM?$.N6OQ%O+%9YKZ>,QVZV M5D\:[8W48W22')'>ONN?_@B#_P`$OKIO,NOV4=&D;U>[N2?UDJ<7BL/AL?R7 M:A!VY4E9KJM];][&F7X'%XW*54Y4YS3?.V[IO9K32W:YYW^PMXY^%W_!6?\` M8FM_CF/!^F^'_B!:7$/A= M^T1_PB7QS\*6K%9VLMVIQ!TLKH,-DF&XP2,;NV01Q7V!^S7^R;^SY^R#X0O/ M`7[.?PTL_"^D:AJ)OKVTLG=A-<%$C,A+L3G:BC\*\;_X**?"KPQ=QZ;\0=(G M6/Q#/)]G-A"A:2^B52V\!>)5JT9UY>S346]%V/J<-2KTL+!5FG- M)7:V;[G4?MD:#X>^+6N:/\&?"GANRO\`Q=J+I*^IF(%]*L5;+.[CD*V3A3P< MGU%=Q\(/V4_A#\)-/LY;3PO;7^K6V'?6;^$23>:/XDW9$>#TVX_&O)/^"=7C M_P`(ZW)K6E:S/))XOGV/)>WDN][JT0!51">0$[K[@_3ZHV`G)KGFW'W3J@HR M]X6BN:\?^,1X&EM+V_;6[ M9;?3Y#'>7#2@1Q.`"5+=,@$9';-39FET:=%4-#URU\0:>FJZ?'+Y$O,$DJ%? M-7LP!YP>V<9ZTS4?%GA_2KI+"\U.+[2_W+6,[Y6^B+DTAFE14=M,9XEE,3IN M&0L@P?Q':B@#\P?^"[?_``4^_8P\3?L'^,_V=?A=\;]%\6^+/%;V5K:67A^[ M%U'`D=Y#-)+)*F4`"1,``22Q''>OD?\`X-M/V]/V:_V0_%OQ*^'_`.T1\0+? MPPGC1=*FTC5=05A;>9:_:E:)W`.PD7(()X^4\BOV6T[]G/P3HW2S#"4\OE MA.1\LG=NZO?3R\CYBME./K9K#'>T2E%62L[6\]?,[[X>?$?P'\6?"=IX^^&7 MC#3=?T6_5FLM5TF]2>"8!BIVNA(.""#Z$$5N'`.<8KA?">B^,O`.A0>%O`_P MF\)Z/IEMN^S:=I=^;>"+)+';'';A5R22<#DDFM+^UOB^3@^"]#^G]N2?_&*\ M5IUNQ M)=P#SX;@O*BY,:^6H8;L9W+C.:^>O^#8/]L+]GGX<_"GQ;^SC\1_B9IF@>)] M4\71WNAV>JW(A&HI)#'$%B9L*SATQLSDY&`:_475_A%9:_XGG\::]^S=\/+W M6;G;]IU:[2.2YEVJ%7=*UJ7;"@`9/``%0/\``_09=5M] M-!$987!R&1_LF58'H0:( M@=PC'EO\YPN5(S7P_P#\&Q7[9?[._P`#M`^('P4^,7Q0TGPUJVOZ[9WNBG6+ MH01WF(O*:-9&^7>"!P2"=PQFOUO\5?#`>/--OV>/`&L:G!!Y,&HZH4N M)XX@2P19)+4L%R2<`XR3ZU3U#X%^'=7FAGU/]ESX9W#P.'A:XMX7,;`Y#`FT MX(/.14T<;0IY?+#.+?,[MW6^G2WD&(RO%5LVAC5-+E5DK/9[W=S\U?\`@XW_ M`."97Q/\>>+[']OW]G7P]=:I=V&FQ6_C73=-C+W""WY@OXU4$L%3".!T$:-Z MU]J?\$UO^"H7[//[9O[.GA[7M0^)>B:/XTL-+AM_%OAW4M1CMY[>[C0+)(B2 M,"\3,"RL,X!P<$5]#G4OBX%V'P5H>,=/[+?B M7^P[\,;_`%.XD,ES?Q7$EM+.YZM(T$*%V/_\`%%W2;[IK9_(^(?\`@X"_;G\/_M/:'X?_`."59S(0[$'""+D\\?:/\`P1X_8&F_X)\_L>Z9 M\,O%+12^+M;NFU?Q=-`V42ZD`"VZGNL4:JF>[;R.#7>?`K]EKP!^S/;RQ?`/ M]E?X>>%7G3;<76DSF.>9?1YOLYD<>Q8UZ.=6^+['/_"&:'_X/)/_`(Q4U\=% MX2.&I*T$[MO=OS[>A>%RV<<=+&XB5YM622T2[+JWYGXB?\'.7P?^(?P]_;7\ M'_M/GP_-/XHSCH:^_OA3_P7N_X)W^(/ M@_X>U0_$Z_F\37>G6\+>"M.T&YN-2:[V!3`D:)M#O$.C78'VK3-9O3O_@F]XI_;S_9PTKXJ_!;1Y;CQUX(1[JQ MTATVRZE8R@-+;`'I*I`=5[D,O4BN9_X(-_\`!2/X7>(/V;-._8\^/OB^S\(_ M$/X=,VEKI?B6<6;WMHK'RRGG%RH.,'C]`_[5^+_!_P"$,T/_`,'D MG_QBO)?CG^Q+\%_VE]2&M_'+]C[X<>(M0"[?[3O+AENB/0SQP+(1[%JRIXV$ M\']6K*\4[IJUU_FC>MEE2GF'US#-*35I)WLUWTV:]#YX_P""W_\`P4T^#OPC M_95\2_LX?"/Q]IWB/XB_$/39-!L]&T&Z6[EL[>Y7RII)!$3M8QLR(OWBS@@< M5SG_``;Z_P#!-OQ+^P[\&_$7[2_[1.G#1/%7C&PC`L=0(C;1])BS*1,3]QG; M#N#]T1IG!!KZB^"7["/P'_9SUI/$WP6_8T^&VA:G'_J=3@N&DNHO]R:6!G3\ M"*]`/#\]O/&T#>&HIVD M[R;M=^7DA0RRK6S!8W$M.45:,5>R[N[U;^1^<_\`P7%_X*S?L>:Q^Q9XO_9N M^#/QGTKQ;XJ\710V)@T"?[1#:P"9)))'F4;.B8`!).:]>_X)-?\`!3#]B#Q] M^R=\,/@I8?&_1=&\6Z/X:L=&N_#6M70MKAKN*-8B(]^%DWL,KM))W8ZU]%Z5 M\`_#.A)LT']E7X8V2GJMI:PQC_QVT%+_`,*'\,+K-OXB7]ECX9#4;6=9K6^% MI#YT4@.0ZO\`9-RL#R"#FB6(P;P:HJ#T=[W6]K;6V'#!YA','B93B[I*UGM> M^]]SY>_X.+OV25_:+_8,O?B-H6F>=KWPUO!K-HT:Y?LQZS^U+XKM)/[2\^%O$WPY\/7FG:E:26U_9W&M2-'/#(I5T8>1R"I(/UJE\/?"?B M?X3^"-,^''PY^%'AG1]#T6S2TTO3++695BMH4&%11Y'ZGD]31',:D$[N] M_+L.64499RL=U4;6\]D_N/$/^"B7_!2K]C']G;X+^/?A_P"._CCHDWBJ3P[? M:?%X5T^Z%Q?&YE@=%C>-,^7RX)WXP*_##_@BE^UU\+OV-?V^M$^+GQFU1].\ M-WVEWNE:CJ"1-(+,3A2LC*H)*!D4'`)`.>U?T3:O\"_#VN^(;CQ=KO[+?PTO M=6NY-]SJ=W;Q27$S?WGD:T+,?887"X6='V;?/N[I?=H(]HH\CNE9OKUU/+OVG/#?[-'_!7 MS]BWQI\%/@I\9O#_`(D6[M8I;+4=)OUF_LZ_0^;;-*H^:/+)@A@"5+>]?DG_ M`,$Q/V^OB'_P1+_:#\8_LN?MA_#C6+/P]JM_&^K00VQ,]A!?AW=?"Z.Y3X:?`+P+X=6]97O%T)UM!.RYP7\JV7<1DX)SC- M8'QT_9K\'?M-:;%I7Q^_9A\`^+(K<$6SZSF?]DBIPF/I4:4 MZ%2+E3ETNKI]T7CLIQ&)K0Q=*:C6CI>SLUV:W/GWQ?\`\'"__!/2TT&%OA5X MGU[QQXCORL6D>%=!T&8W=W<-PD7S@!23QWKZ-_9#U3]I+XA?!:;Q;^USXZ13U"S20,Z@]P",UZ^-5^+YY'@O0__``>2?_&* MX\1/"6Y_OOA-J.NW*V&IV\99)=(N]PEM';H+B`,&`)&\PJ>A./VU=7X\\)^)/BCX8NO!/ MQ)^#?A#7](O4V7>EZQ?&YMYA_M));E3^7%>*>$O^"7/[(G@7Q6GC;PU^P9\+ MH=1CE$D4DUS).D;@Y#+'+"T:D'IA>*ZL1C:&.A%UTU.*M=6U7G?K]YQ83+<7 MEE2<<+).G)WL[W3>]K;H_$G_`(*I?MB>&/C?_P`%1K3]J/PWX0U:R\.Z=/H= MQI"ZI;&&?4[*T=76Z6-L%4EVL4SU7:>]?MC\7K/X"?\`!:/_`()[^*?!?PLU MJ].GZ[;!=+OM4TN6U>SU*$K-`Q611D!PH)7((+#-=\W[*/P[G^,=W^T!??LL M^`+SQE>06\4NOW]R9YXT@C$<2Q>9`1#M50/D"]*])CU'XM0H(X_!&@JH'"KK M<@`_\@5IB\SHUJ=)4H.,J:5G?TZ==NYEE^35\/4KNO-2C5;NK-;WZWTW/P4_ MX)F?MV_$C_@B#^T=XQ_9D_:^^&^KVOAS6+N-]7@AMR9K*XCRD=[`#@31.AP= MI^8!2#\N*_2SQ;_P<+_\$[[/P]%-\,O%6O>-/$-\5BTCPKH7A^8W=U<-PD7S M`!22<=37T%\=/V;O"/[3&E1:-\??V9/`/BR&WR+9M:N3+)!GKY6YMET?84:L72Z73;2?16LOO#X#_M)?%GPK\!KKXL M_MLG1_#OB#6=1FOM%\#Z:RFZTJP94%O9RG.99^&9W(`!?'\-7?V5XG^-NN:C M^TEXYO;:ZOKMY+/1=+24.NEV@."-O9F[D]1D]ZW-3^`6DZWK-UXAUCX`>$+J M]O93+=37&LS.7<]3S#@?A5[P/\*+KX:ZK/K7@3X,^&-,N;B+RYI;;79QN7.< M8,)`Y]J\F_2A*,(Q;;MU>[\V?*_P"TWX8C_9H_:*@\4_"O6H8? M-(O[:W@E#&UQKZU^`W[1G@3XX>%+;4M/U>VMM5*!;W29;A1+ M%)WV@G+*>H(]:YZZ_9T\/WNI3ZU>_L^>$9KFZF:6XEFUJ=R[L1:C;_L\^$(KBWE66&6'69TV.IR#\L0[BB4HRBD]RHJ4976QYU^V7'^T M1K?Q1MM8^%WA/5SI_A[39(8M1LX,GS)E(E9!USL.W(';BO-O@_\`%S4-8N;/ M0/$'A+5-=.BOC2?"%D#%;>=G+7-Y(WWV+$D[N_H.*T[3XO\`[73?M*+I-Q/J MPG.M>4^B"-C:B#?@@#&TKMYW]>^:F_:R\'>']4_:L?3?"L&BF>ZTV"34K?4M M1%K`]V2V5+9`W%/+)&IK1*R460W=\R/9+?Q1XS\6@7'QH^/7A[PC8-_S M+OAK5(5N6']V2X8EAZ$(!^%>E_#:W^&.GVGD?#NQW(_W[Q;>5C-_M--(,O\` M7<:\?^&7PN_:#\%Q13^&O@[\,+$X!6Z$\CRD>OF!&)_[ZKU/2)_VD6P-:TWP M;&._V>>Y;^8%8RMT-8L[NBLO2U\9;0=:ETS..1:QR#'_`'TU%0:&I1110`44 M44`%%%%`!1@>E%%`!1110`8`Z"BBB@`HHHH`****`"BBB@`HP.F***`"BBB@ M`HHHH`,#&,4444`%%%%`!1110`4444`%%%%`!@=<4444`%%%%`'R=\?_`(O? MM)>!/CNGPP@\=VUCI>O2J-(U-M)AW112':%+A<_*W!/7O6/X%^$?Q"T&?5/$ M6J>&4\37UG=>7XY\(:PHEEN0>5O+61N2'7D#U5ADC@>U?MD?!V7XG?#)M=T& MWW:[X;E^WZ8R#YG"\O%^(&1[J*[CX>T58RY&Y:G+?"7PKX/OM"A\4?!#QKJ.G6;G$ND7+FXMX7'WHGA MD.Z)@>"%93Q7I-F;T0`:@(_-`^8PYVGW`/(^G/U-8%YX`M;/Q&_C3P@RV&HS M8%^B#$-^H[2J/XAV%7FCV,1\RYS@^E9MW-$K#Z***0PHHHH M`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@` MHHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`:R*RE7`((Y![UB^!O#UEX4T EVX\-Z9D6MM?2M;H1_JUD(EV#V!D('L!110!N4444`%%%%`'_V3\_ ` end GRAPHIC 6 gtlogo.jpg FAHN KANNE & CO. GRANT THRONTON ISRAEL LOGO begin 644 gtlogo.jpg M_]C_X``02D9)1@`!`0$`8`!@``#_VP!#``@&!@<&!0@'!P<)"0@*#!0-#`L+ M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7& MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0`'P$``P$!`0$! M`0$!`0````````$"`P0%!@<("0H+_\0`M1$``@$"!`0#!`<%!`0``0)W``$" M`Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O`58G+1"A8D-.$E\1<8&1HF M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$ MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4 MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H`#`,!``(1`Q$`/P#W^BBB@`HH MHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB M@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BD9U12SL%4=23@" ML]]>TF-]C:C;!O3S!32;V`T:*B@NK>Z7=;SQRKZHP/\`*I:0!1110!RVG:AK M6J:A>^7?Z?#!;WTEN(6@+.R(1SG>.3]*OGQ/IMPEU'97:2W,44CHI5@KE!SM M)&&P>N":H:!HD4-SJU_/ID8OSJ$[P32Q@,5/W2&ZX-<]#!J>H7VGSS6NJO/:M:QLKF/Q'I4K6\BQ1Z08G;;@*^Y/E/OP? MRI2A"UT%D,O?%,MEJ&J6?E1RW"30V]A`#AII'CW8)]!R2>P%:5QKMIHT-O#J M]Y&+MH]\GE1L1Q]YL#)5<]S7/7OA9]4USQ%>B%XKW_1SI]TW171`(MR65"NTD*S?=4MC` M)[`GFM2O/+G2G&H:K8WJ:U(MY?BXBBM%7R95)0@ER/E*E>/J?:M6O)?$FJB^U"YO)9`L$9*H6/"H/\>M;4:?/+78 M:5S)UW6M0U:5GN[EV7^&-3A%^@KFVU*YLGRC[U'5'Y!_PJ&^\1+)(4M8"XS@ M,_?Z`5UVF?#+7M7TLW=X]O82NNZ*!P2Q_P![^[^M>K[M**Y]$:[;D&D:TEQ& M+JS=X)D.&"MAE/\`45Z+X:\7?;I5L;]E%PW$)7L+^ M%H)B-KJ>C#J&![CWK:%Z58,KE64Y!'4'UK.M0C/83B?05%9GA[4_[7T&TO&^ M^Z8?_>'!J]<7$5I;2W,[A(8D+NYZ*H&2:\EIIV9D2T5Y'IFH>+_BE<7%[INJ MOX>\-QR&.!X4!GN,=3D]/\CFK=WX0\?>'4^W>'O%]QJ[Q\M8ZFH(E'H&SP?R M^M(#U&BH+-KE[*!KR-([DQJ94C;)M% MT*6VGEGU9V6.1,;4QU+9Y_*@#HZ*P/%&@ZAKUO;Q:?X@O-&:)RSR6J@F0$8P M/-8,<]H;DW.%W`@-QMZ=J`/Y7QA MJ=_<3W]NBRRX1HU^;/RKUY"3&I/7`H`=1110`4444`%%%<[XQ\76O@S M28=0N[:>X66X2W5(<9W-G!.>W%`'144@.5!QC(I:`"BBB@`HHHH`****`"BB MB@`HHHH`CN,BVE*_>V''Y5\ZZ[+)1_A^%=N"DE)EP91^'MIIR^-K$:@%R0QMPW0R@<9_7'O7O M]?,VNVTD,$%S$65HI,[E."I['/U%=MHOQ=OX](\B]L%N[U%Q'.)-@?W<8Z_2 MML30G5M..HY1;U-GXOQ:66LDE[=1V\7+. M?R'W"@$[8U_NJ/2MS1]+@TZ,B(%Y7X9SU/L/05O3BJ M5-1;NREHCU'P"I3P^Z?P+.P7Z8%1_$]Y(_AGK[1$AOLI''H2`?TS6UX?T\Z9 MHEO;N,28WO\`[QY-6=1L(-4TVYL+I=T%S$T4@]B,&O(J.\VS)[G.?#!(H_AK MH(A`VFV!./[Q)S^N:H>(_'FNZ!=W^/!=[)/A2DNAZKHM[JVA)(S6E]8IO9%)SAE_7'8YZBK>O>.[_QEHMYH7ASPEK$T ME[$86N+N+R(X@W!))J!%#QWXEO\`7_#?@?5=+FFTN;4;X!=LA.PGY1G&`P'7 M%;E_X);PKX4U06/C"YL);YXVN]2U&7<5`SG9TVELUB^(O"FJZ5X;^'NDK;R7 MDVGZ@AN'MHRRH,Y)/H!GJ:V?C%I.HWUOH-];:?+J5CI][YUY91#<9%XYV]^A M'XT#//\`Q)<>#=$T9-1\'^+KZ77[:1&#&YE?SQGYL@C;[_I78?$*[U:]\1^` MXM-U&:PN-0+!I(F.%W*N3MZ'`)QFL_QWK-QXO\%7-CX;\(:E'$A1YY9K,1%0 M&&$C7JQSCIT`-;?B33+^;Q;\.)8K*X>.U/\`I#K&2(OD7[Q[?C0!@^.?"K_# MR+3/$NBZWJSW0OHXIQ=7)D$P;.<_D:?XR\(>(ETZ M[N[&PD?[1]EB,C)G&.!^/Y4`>CZ/IB:-I%KIT<\\Z6Z!!+:=?-^T%IVH+ M9W!LETQD:X$9\L-A^"W3/-`@^.FX>`(=F-_]H0;<^O.*Q?&7P^ETOP?=^)3X MDUB77K6(7#SFY(1FXR%4?='IBNC^,MA>:CX*@@L;2>YE&H0.4A0L=H)R<#M6 MS\0K:XN_AQK5M;0233R6A5(HU+,QXX`H`XG7_%FMZOH?@K0M/O&L]0\0Q(US M=H,,B`#<5]">3^%+XJ^'0\)^&[CQ!X_I4.H M^&-!_$>E6$DVJ:'`GG6+#:[H0,@#U'/'7GVJUXC\;:IXR\/S^']`\+: MS'?WR^3-)>0>5%;J?O$L>M`S.\6:_JGB33_AU>Z??2Z==:I,R.\3$!7.U6.. M^#G`-2>//#/_``@?PXNCI>K:G-/CS?#33 M+2WFNH],N\7$T49*K]TECZ#.>M;GQFL+S4?`?D6-K-)-8EUZW@%RTYN2$+#!(5!]T>F*Q/B);OK7P]\,>*;J\N MC>7*V]O)$)/W1)R2^W^]GO7J_CBVN+GX;:O;6\$DL[V)58D4EF.!P!ZUY[XI MT359O@7X6>W$9\Q54'/R]>,B@1=\3Q7WA'3M$\&^'M6OC=Z[ M>D->W4OF2PI\H.T]O_UT[Q)\,U\.>&[G6]`US6(M8L(C<&:2[9Q-MY8,IXY& M:;XF>^\::?H_BSPUI=\+_0;O<;2\A,3S+A2P4'KC'X\U+K_CW4_%/A^XT+0_ M">M)J=]&8)#=6_EQ0!N&)<\'C-`S(\5>)]5\0^%O`&IV%X]E?WUYY;O$2%$G MW22.A&1G!I?B#X-?P3H2>*=+\0:Q)JEO<1F62XN2XER>>.W/;IBKOB#PA>Z+ MI/P[TFUMYKLZ?J"MH_#F[M[&UFN9S-$1'"A= MB`W/`H`[>RF-S8V\[#!EB5R![C-3U5TQ632;-'4JRP("".0=HJU0(****`"B MBB@`HHHH`*Q/$?AZ+7;92"$NHO\`5R'^1]JVZ*<9.+N@/&-2T:2V,EIJ%N4# M`J0W1A['O7(3:'<:?*3'F:#LR]1]17TE/;PW,9CGB25#_"Z@BLI_">AN^XZ? M&#_LD@?SKMIXRVZ+4SQ&Q5W=8T1FE6&G_`/'I:0Q'^\J\_GUJY6=7$N:M%6$Y7"BBBN4D**I2Z:LLK2&Z MO%W'.U)R`/H*9_92_P#/Y??^!#4[+N!H45G_`-E+_P`_E]_X$-1_92_\_E]_ MX$-19=QFA16?_92_\_E]_P"!#4?V4O\`S^7W_@0U%EW`T**S_P"RE_Y_+[_P M(:C^RE_Y_+[_`,"&HLNX&A16?_92_P#/Y??^!#4?V4O_`#^7W_@0U%EW`T** MS_[*7_G\OO\`P(:C^RE_Y_+[_P`"&HLNX&A16?\`V4O_`#^7W_@0U']E+_S^ M7W_@0U%EW`T**S_[*7_G\OO_``(:C^RE_P"?R^_\"&HLNX&A16?_`&4O_/Y? M?^!#4?V4O_/Y??\`@0U%EW`T**S_`.RE_P"?R^_\"&H_LI?^?R^_\"&HLNX& MA16?_92_\_E]_P"!#4?V2O\`S^WW_@0U%EW`T**11M4#).!C)I:0@HHHH`** M**`"BBB@`HHHH`****`"BBB@`HHHH`QO$_B.W\+Z1]OG@EN"TBQQPQ8WR,>P M_`$_A5_3-0@U73+74+8YAN(ED3Z$9Q7#^(M3DN?B%901:9=ZE;Z/"9Y8K55; M$T@PN*-(\NYL;G2TEGM8YL"2.%P63ID<'/Z5T^PO3 M36_^?]+[RN70]0JIJFHQ:3ITU]/'-)'$`66&,NYR0.%'7K7`L=8TNT\+:T^O MWUS-?W%O%=02E?)99%[*!P1ZUTWCR]NM.\%:E=6<[P7$:J4D0X*_.HJ/96E% M7O<5CH@=R@^O-+7"-%J6N>.-6TPZW?6=C!:6\BI:L%;>P/(8@X''([UD0ZGX MCO?"NER&?4KBWAO;B#4)]/`^TLB,50C\N<YJ)]2A36(],, MOZENAOKJ^T_Q9;Z:FH7,D":)/(3(P)>16`# MGC[U/V-EOKK^`6.UHKRE)M;M?!6A^*'\0W\UW)+;B2!BODNCN%*E<=<'KGK6 MW:QZEXMUG76_MN]TZ#3[HVEM#9LJX90"7?(.[)/3IBDZ%M6]$'*=H][;1WD5 MF\\:W,JLT<1;YF`ZD#VIUU<1VEI-D74GQ)T!)]8O/ M/:QD9Y8MJ#*;<[1@X#=Q76>+;9KKPIJD:7,UN1;.^^(@$X4G'/8XP?8TG32< M==Q6%\.:Y/K]C]M?2Y[*WD"O;M*ZL94/(.`>/H?6MFO+M)_M!-.\*Z!;:Q>1 M)JEN;F:^M99W#2P.IV MD;L<@]1FKE0O*T7_`%L/E/3**PO"UA=6VEI=7FJW=_/>1QRN9R-J$KT0`<#F MN8TXZIXDTS5]?;7;ZS:&>>.TM[8J(XUCR!N4@[B<@45Y=I7C/4(38ZOJ=PQM;W29F,?1!<0,,W,:"1X@WS*IZ$CT.*I>'];B\0:7]NAA>)/-DBVN03E&*D\?2N3T[ M2Y/^%N:M)_:5[B.UAF*;QAPQ;]V>/NCL/UKG;*VU&T^'-_KUKK=[;2V=Q/)! M;Q$"+`E.0XQ\V>>]-4(M6OKI^(6/3(K+58[^-SJ"O:AB7C96P`<>A7_OF MM:HK60S6D,K8W/&K''J14M-NYXZCL:WJ*OGE>]QW,:Y\-6EUIVE6+RS"/39898B",L8Q@;N/SJS MKFCP:]HUQIER\B0S@!FC.&&"#Q^5:%%+GE=.^PKF9:Z';VFN7FK(\AGNXHXG M4D;0$SC'YUF)X-2VT^.TL-8U*R,<\LXDAD7+&1MQ#`C!`[>E=-13527<=SEY M/`U@^@'2UNKM9#="]-YO!E,^<[R<8_#%7/\`A&(9+Z"]N+RYGN8K%[(R,5&] M6()8@#[W%;E%/VL^X79S\GA&QD\+6?A\S3_9;4Q%'##>?+8,,G&.HJ&]\'1R MZK/M2VK+ME(&`V&!PV.XKIJ*%5FNH79SVH>%([RZTR[CU.^M M[O3XS$DZNK-(AQN#Y!SG'6MJ]M4OK&XM)"P2>)HF*]0&&#C\ZGHJ7-NU^@KG M/77@^QN=(TRR6XN8)=,51:7<3@2QX7;UQ@Y'48P:A3P19M::DMY>WEY=ZC!] MGGNYG'F"/^ZH`PH[]*Z>BJ]K/N.[(K6W6TM(;9"2D,:QJ3U(`Q7F>LVD%IVD`21CP2,@E2>^*ZF MBCVL[WN%V!8FQP/X3GJ#W]:L?\(KI_P#PEP\2 M?O/M@@\D+D;,=-V,=<<5N44O:3M:_P#3"[,.;PU&WBA=>@OKJWF,:Q3Q(5*3 M*I)`.1D=>U1+X0L5\*77AX37'V6Y,A=]PWC>Q8X.,=370T4>TEW_`*078R&( M0P1Q*2510H)]ABGT45`@HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`*** M*`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH M`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@` JHHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`__9 ` end